{"transactions":[{"id":813076,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2026-04-07T23:45:05.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":8069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8069},"source":{"system":"sec-edgar","filing":"0001193125-26-145942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000119312526145942/ownership.xml","form_type":"4"}},{"id":813075,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2026-04-07T23:45:05.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":7895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2027, subject to the terms of issuance. Such shares remain subject to a deferral election by the Reporting Person in accordance with Treasury Regulation 1.409A-2, and the vested portion thereof will be distributed as shares of common stock following the Reporting Person's separation of service from the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2027, subject to the terms of issuance. Such shares remain subject to a deferral election by the Reporting Person in accordance with Treasury Regulation 1.409A-2, and the vested portion thereof will be distributed as shares of common stock following the Reporting Person's separation of service from the Board."}],"balance_after":7895,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7895},"source":{"system":"sec-edgar","filing":"0001193125-26-145942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000119312526145942/ownership.xml","form_type":"4"}},{"id":813074,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-07T23:45:05.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":8069,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33597,"source":{"system":"sec-edgar","filing":"0001193125-26-145942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000119312526145942/ownership.xml","form_type":"4"}},{"id":1182233,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2025-04-02T18:40:47.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":9317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9317},"source":{"system":"sec-edgar","filing":"0000950170-25-049177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000095017025049177/ownership.xml","form_type":"4"}},{"id":1182232,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2025-04-02T18:40:47.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":8069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance."}],"balance_after":8069,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8069},"source":{"system":"sec-edgar","filing":"0000950170-25-049177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000095017025049177/ownership.xml","form_type":"4"}},{"id":1182231,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T18:40:47.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":9317,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25528,"source":{"system":"sec-edgar","filing":"0000950170-25-049177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000095017025049177/ownership.xml","form_type":"4"}},{"id":1552452,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2024-04-02T21:12:33.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":false,"shares":6419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6419},"source":{"system":"sec-edgar","filing":"0000950170-24-040354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000095017024040354/ownership.xml","form_type":"4"}},{"id":1552451,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2024-04-02T21:12:33.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":9317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance."}],"balance_after":9317,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9317},"source":{"system":"sec-edgar","filing":"0000950170-24-040354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000095017024040354/ownership.xml","form_type":"4"}},{"id":1552450,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T21:12:33.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":true,"shares":6419,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16211,"source":{"system":"sec-edgar","filing":"0000950170-24-040354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1846675/000095017024040354/ownership.xml","form_type":"4"}},{"id":1933009,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2023-04-03T13:58:17.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":false,"shares":5485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":5485},"source":{"system":"sec-edgar","filing":"0001209191-23-022065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123022065/doc4.xml","form_type":"4"}},{"id":1933008,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2023-04-03T13:58:17.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":6419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2024, subject to the terms of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2024, subject to the terms of issuance."}],"balance_after":6419,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":6419},"source":{"system":"sec-edgar","filing":"0001209191-23-022065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123022065/doc4.xml","form_type":"4"}},{"id":1933007,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-04-03T13:58:17.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":true,"shares":5485,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9792,"source":{"system":"sec-edgar","filing":"0001209191-23-022065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123022065/doc4.xml","form_type":"4"}},{"id":2309372,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2022-04-04T17:06:54.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":4307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period on April 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Shares vested at the end of a one-year vesting period on April 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":4307},"source":{"system":"sec-edgar","filing":"0001209191-22-022515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122022515/doc4.xml","form_type":"4"}},{"id":2309371,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2022-04-04T17:06:54.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":5485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2023, subject to the terms of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2023, subject to the terms of issuance."}],"balance_after":5485,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":5485},"source":{"system":"sec-edgar","filing":"0001209191-22-022515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122022515/doc4.xml","form_type":"4"}},{"id":2309370,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-04-04T17:06:54.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":4307,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4307,"source":{"system":"sec-edgar","filing":"0001209191-22-022515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122022515/doc4.xml","form_type":"4"}},{"id":2706341,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":53358,"kind":"person","name":"Temeng Kwaku","position":1,"cik":"0001846675","reported_name":"Temeng Kwaku","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Shares","published_at":"2021-05-19T17:07:05.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":4307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares were granted to Mr. Temeng upon his election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2021, and will vest, without performance criteria, on April 1, 2022, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares were granted to Mr. Temeng upon his election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2021, and will vest, without performance criteria, on April 1, 2022, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance."}],"balance_after":4307,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":4307},"source":{"system":"sec-edgar","filing":"0001209191-21-034045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121034045/doc4.xml","form_type":"4"}}]}